Public Health and High-Tech in China

Asia Research Centre Seminar with Professor Jan Annerstedt.

Introduction by Professor Jan Annerstedt followed by a roundtable discussion.

Clustering innovative capabilities in Shanghai’s health district: How to set priorities for biomedical and related R&D, foster innovation in biotech and other industry, and advance health care services?

For half a year, together with colleagues from across Europe, Jan Annerstedt has developed a conceptual design, master plan and implementation strategy for modern China’s largest investment in science-based health care, located in the center of Shanghai (Xuhui district). With his colleagues, he continues to work on this project and the shaping of other innovation environments in China. In this introduction, Jan Annerstedt will present the Shanghai Fenglin Biomedical Center as a localized ‘innovation cluster’ in biomed and health care with global linkages, involving a wide range of stakeholders, including R&D institutions and highlyspecialized researchers in the life sciences, hospital clinics, service providers from many sectors, other supporting institutions, and business firms from China and from abroad.

In the conceptual design for the Fenglin Biomedical Center there is room for a school of management, specializing in biotech and life science-related business development. Could this become a joint venture with the Copenhagen Business School?

Professor Jan Annerstedt is completing a five-year tenure with Copenhagen Business School, where he has held the UNESCO Chair. He is currently teaching International Business at the CBS MBA program and a master course in Organizational Intelligence. His work in China in 2004 combined research and a consultancy assignment under the auspices of HPP (Germany) and Interlace-ie (United Kingdom).